Next Article in Journal
Detecting and Explaining Long-Term Trends in a Weed Community in a Biennial Cereal–Legume Rotation
Previous Article in Journal
Abscisic Acid Can Improve the Salt Tolerance and Yield of Rice by Improving Its Physiological Characteristics
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Antimicrobial and Antioxidant Properties of Sambucus nigra L. (Elderflower) Oil: A Molecular Docking and Biochemical Study

1
Faculty of Agriculture, University of Life Sciences “King Michael I” from Timisoara, Calea Aradului 119, 300645 Timisoara, Romania
2
Department of Biochemistry, Faculty of Life Science, Ahmadu Bello University, Zaria 810107, Kaduna, Nigeria
*
Authors to whom correspondence should be addressed.
Agronomy 2025, 15(2), 310; https://doi.org/10.3390/agronomy15020310
Submission received: 7 December 2024 / Revised: 20 January 2025 / Accepted: 24 January 2025 / Published: 26 January 2025
(This article belongs to the Special Issue Tissue Structure and Plant Phytochemicals)

Abstract

:
The present study investigates the antimicrobial and antioxidant potential of an essential oil extracted from Sambucus nigra L. flowers. Using hydrodistillation, the volatile compounds were profiled through GC–MS analysis for the fatty acid profile and volatile compounds. The fatty acid profile demonstrated a balanced composition of saturated fatty acids, monounsaturated fatty acids, and polyunsaturated fatty acids, with oleic, palmitic, and linolenic acids as key contributors. The volatile profile revealed the dominance of nonanal, cis-rose oxide, trans-rose oxide, and 2-Pentadecanone, 6,10,14-trimethyl-. Antioxidant activity was assessed using the 1,1-Diphenyl-2-Picrylhydrazyl radical scavenging assay, showing significant inhibition, with an IC50 value of 2.52 mg/mL. Antimicrobial efficacy was determined against Gram-positive, Gram-negative, and fungal strains, highlighting moderate inhibitory activity for Streptococcus pyogenes, Staphylococcus aureus, and Candida albicans. The S. nigra essential oil exhibited more activity against fungal strains, especially C. albicans, compared to the bacterial strains, which might be attributed to differences in the composition and permeability of the cell wall between fungi and bacteria. Among the bacteria, E. coli was the most susceptible, while P. aeruginosa showed moderate resistance, in agreement with its known stronger membrane structure and efflux mechanisms. Molecular docking analysis was conducted to evaluate the potential inhibitory effects of the oil on microbial proteins to corroborate the observed in vitro outcome. The results indicated that nonanal, cis-rose oxide, trans-rose oxide, and 2-pentadecanone, 6,10,14-trimethyl- displayed interesting hydrophilic and hydrophobic binding interactions with the putative microbial proteins. These findings elucidate the bioactive role of Sambucus nigra essential oils, suggesting their potential as therapeutic agents in managing oxidative stress and microbial infections.

1. Introduction

The use of medicinal plants as remedies for various pathologies due to their bioactive compounds has been reported since ancient times. Although modern medicine has long disproved their biological potential, currently, research is based on the identification of some natural bioactive compounds from medicinal plants that, on the one hand, have a beneficial effect on the body’s energy and vitality and on the other hand, replace the synthetic products used for the treatment of diseases [1,2,3,4,5].
Sambucus L. is a genus of the family Adoxaceaein, consisting of more than 20 flowering plants that grow from the temperate to subtropical regions of the world [6,7]. S. nigra, or black elderberry, is a deciduous shrub native to Europe, North Africa, and parts of Asia. Thriving in temperate regions with moist soils, it has been valued for centuries for its medicinal and culinary uses. Over time, it spread to other parts of the world, including North America, becoming both naturalised and integral to herbal medicine and folklore. Among the Sambucus species, the most cultivated and studied are Sambucus nigra L. (native to Europe and western Asia) and S. nigra ssp. canadensis (native to eastern North America) [6]. The most known and studied species is Sambucus nigra L., which due to its variety of bioactive compounds, has been demonstrated to exhibit multiple beneficial effects [8,9]. At the present time, the elderberry crop has been introduced and also grown in many countries of the world, and the prospects for its use also depend on the interest of the public and the processing industry. Elderberry (Sambucus nigra L.) is cultivated in Central Europe, particularly in Romania, where it holds economic and agronomic importance. The plant thrives in the region’s temperate climate and fertile soils, making it ideal for large-scale farming. Romanian elderberry cultivation aligns with sustainable agricultural practices and meets the growing demand for its versatile applications. The flowers and fruits of elderberry are used by the food, cosmetic, and pharmaceutical industries, as well as in phytomedicine. The flowers are harvested and processed to produce herbal teas, which are widely appreciated for their health benefits, including their antioxidant and anti-inflammatory properties. These teas are a key component of natural remedies and wellness products. In addition to their flowers, elderberry fruits are utilized in the production of various food products, such as jams, juices, syrups, and dietary supplements, owing to their high content of vitamins, anthocyanins, and other bioactive compounds [10,11,12]. The effects demonstrated include cardiovascular protection [13], as well as antidiabetic [14], anti-tumour [15], antibacterial [16], antiviral [17,18], and anti-inflammatory [19,20] properties and antioxidant capacity [7,18,21]. The biological potential of various extracts derived from Sambucus nigra L. is closely linked to their chemical composition, which is influenced by factors such as cultivar, geographic location, ripening stage, and climatic conditions [7], and not least of all, by the extraction methods [22,23,24,25]. Generally, methanolic or aqueous fruit and flower extracts are rich in polyphenol as a plant secondary metabolite, classified into phenolic acids, flavonoids, anthocyanins, and lignans [20,23,26,27]. The chemical composition varies depending on the part of the plant used. The crude oils extracted from leaves are rich in fatty acids, including methyl linoleate and palmitic acid, along with the hydrocarbon tritetracontane and the aromatic compound benzaldehyde. The oil derived from flowers predominantly contains the hydrocarbons tritetracontane and n-hexatriacontane. These are followed by fatty acids and their derivatives, such as palmitic acid and linoleic acid, as well as alcohols, including 2-methyl-3,15-octadecadienol and 2-hexyl-1-octanol [28]. Instead, the essential oils (SNEO) obtained by hydrodistillation of Sambucus nigra L. reveal terpenes as their main class of compounds. Regarding the concentrations of terpenoids, Sambucus nigra L. essential oils are overall characterised by the predominates of different types of monoterpenes [28,29,30]. The elder fruit essential oils contain high amounts of β-damascenone, linalyl anthranilate, and linalool [29]. Those from flowers contain high concentrations of other monoterpenes, such as phelandrene, α- and γ-terpinene, terpinolene, safranal, carane, rose oxide, and epoxylinalol [28,29,30]. At the same time, the essential oils extracted from leaves are characterised by small amounts of monoterpenes, such as β-pinene and α-pinene [28].
Natural antioxidants, known as protective agents responsible for reducing the oxidative damage of organisms, are considered to be different phenolic constituents, i.e., flavonoids and terpenes. These compounds are found in variable concentrations in other plants, including Sambucus nigra L. The antioxidant capacity is based on their ability to interact with free radicals that initiate oxidation reactions or are produced during chain reactions upon the inhibition of oxidation processes, which reduces the activity of oxidase enzymes, or upon the complexation of transition metal ions, which catalyse oxidation reactions [31,32,33,34]. The berries and leaves of Sambucus nigra L. usually display a lower antioxidant activity than do the flowers [7,35] because elderflowers contain larger amounts of certain phenolic compounds (rutin, isoquercitrin, and astragalin) [34,36,37]. The antioxidant activity of elderflower essential oils is almost double that of leaf essential oils [28]. However, different chemical compositions in various regions imprint the antioxidant power. Gentscheva et al. [38] found that the extract from blossoms of Sambucus nigra L. from the Rhodope Region, Bulgaria, had the highest antioxidant activity. In contrast, the sample from the Dobrich Region has the lowest antioxidant activity. The difference is probably due to the higher altitude and lower temperature in the mountain regions, which influence the accumulation of secondary metabolites [38]. On the other hand, elderflower extract from lyophilised plant material demonstrated an antioxidant activity five times higher than that of the extract stabilised by freezing or using the air-drying method, since it contained from 96% to over 500% more polyphenols [39]. Thus, it is evident that various intrinsic and extrinsic factors are responsible for the efficacy of the antioxidant activity.
Concerning the antimicrobial activity of Sambucus nigra L., several previous studies demonstrated that the extracts displayed great activity against both Gram-positive and Gram-negative bacteria, respectively, particularly against the bacteria from the genera Staphylococcus, Streptococcus, Corynebacterium, Pseudomonas, Escherichia, Enterococcus, Klebsiella, Bacillus, and Proteus [40,41,42,43]. Instead, limited data are available regarding the antimycotic activity; the elderberry extracts demonstrated efficacy only against Candida albicans [44]. The ability of Sambucus nigra L. to inhibit or stop the growth and reproduction of microorganisms is attributed to the synergism between different phenolic acids and flavonoids rather than to certain compounds considered individually [41]. On the other hand, anthocyanins are the active compounds against Gram-negative bacteria [43].
While numerous studies have investigated the chemical composition and biological properties of various extracts [7,29,30,34,36,37], there remains limited knowledge about the compounds and bioactive potential of essential oil derived from Sambucus nigra L. The purpose of this research was to evaluate the antimicrobial activity of the essential oils against specific bacterial and fungal strains. This design was chosen to focus on the efficacy of the oils themselves and to explore their potential as natural antimicrobial agents and not as direct alternatives to existing pharmaceuticals.
The current study employed the computational in silico method in assessing the antimicrobial and antioxidant potential of the compounds identified in SNEO essential oil against target proteins. Molecular docking of the compounds with the proteins interfered with the action of the oil in regards to protein synthesis by blocking the tyrosyl-tRNA synthetase pathway (TyrRS) and peptidyl transferase activity, the protein prenylation pathway [45], and the plasma membrane fungal pathway [46], which would interfere with the microbial protein function [47,48,49,50]. Conversely, the free radical generation usually promoted by microbial infections would affect the catalase and glutathione peroxidase mopping activities, destabilising redox homeostasis and potentially altering cellular lipid peroxidation and DNA and protein expression [51].

2. Materials and Methods

2.1. Chemicals

The chemicals used included ethanol, 1,1-Diphenyl-2-Picrylhydrazyl, ascorbic acid, potassium hydroxide, hexane (Sigma-Aldrich Chemie GmbH, München, Germany), potassium hydrogen sulphate, and dimethyl sulfoxide (Geyer GmbH, Renningen, Germany).

2.2. Samples

The elderflowers were collected in May 2023 from a natural site in Dudestii Noi, 45°50′51″ N 21°06′30″ E, Timis County, Romania. The freshly harvested flower clusters were carefully selected, and any parts of the plant unsuitable for processing were removed, leaving only the superior plant material.
The plant vouchers (VSNH.ULST-BD72) were deposited in the botanical collection of the herbarium at the Botany Department, Faculty of Agriculture, King Michael I University of Life Sciences in Timisoara. The samples were air-dried under ambient conditions, with periodic turning until a constant mass was achieved. Once dried, the samples were stored in paper bags at 18–20 °C in the absence of light.
The essential oil was extracted from dried SN flowers using a Clevenger apparatus. A total of 30 g of flowers were placed in a distillation flask containing 300 mL of distilled water. The mixture was then boiled for 4 h. During this process, the vapours produced by the boiling were condensed, resulting in two phases, with the upper phase containing the essential oil. This oil was collected, poured into coloured glass vials, and stored at 4 °C. The essential oil yield (Y) was presented as a percentage and determined using the following formula:
Y = M e M p × 100
Y represents the percentage yield of essential oil, Me is the mass of the crucial oil in ml, and Mp is the mass of the plant material in grams [52].
AOAC method no. 2003.06 was used to ascertain the crude fat, which was determined using the Soxhlet method, using petroleum ether as an extraction solvent and Soxtest Raypa SX-6 MP equipment at 70 °C and a 60 min extraction [53]. A total of 5 g of pulverised flowers was introduced into the cartridges, and 50 mL of petroleum ether was used for each sample to extract lipids. The crude fat was collected, poured into coloured glass vials, and stored at 4 °C. The oil yield (YO) was presented as a percentage and determined using the following formula:
Y O = ( M o M p ) × 100
where YO represents the percentage yield of oil, Mo is the mass of the oil in grams, and Mp is the mass of the plant material in grams.

2.3. Fatty Acid Profile

Before gas chromatography (GC) analysis, the fatty acids in the oils were derivatised into methyl esters (FAMEs) using a 2M potassium hydroxide in a methanol solution. The oil was combined with 4 mL of hexane; then, 400 µL of a potassium hydroxide solution was added. The mixture was then vortexed for five minutes. Subsequently, 500 mg of potassium hydrogen sulphate was introduced. The organic phases were separated by centrifugation at 3000 rpm for 15 min and then transferred to vials for GC analysis. Fatty acid methyl esters (FAMEs) were identified using a Shimadzu GCMS QP 2010Plus instrument (Shimadzu Corporation, Tokyo, Japan), equipped with a mass spectrometer (MS) detector and an AT-Wax capillary column (30 m × 0.32 mm × 1 µm). The injection volume was 1.0 µL, with the injection port temperature set at 250 °C. Helium was used as the carrier gas at a flow rate of 1.8 mL/min, and a split ratio of 1:10 was applied.
The oven temperature was initially set at 110 °C and increased by 8 °C per minute until reaching 250 °C, where it was held for 7.5 min. The MS parameters included an ion source temperature of 210 °C and an interface temperature of 255 °C.
The identification and quantification of FAMEs were performed using the NIST05 library and the area normalization method. The results of the fatty acid (FA) analysis were expressed as a percentage of the total FAMEs.

2.4. GC–MS Volatile Compounds Profile

The essential oil of SN was analysed using gas chromatography–mass spectrometry (GC–MS) on a Shimadzu QP 2010 Plus instrument (Columbia, SC, USA), equipped with an AT-WAX capillary column (30 m × 0.32 mm × 1 µm). This was achieved by dissolving 20 µL of the essential oil in 1480 µL of hexane. From the resulting solution, a volume of 1 µL was injected into the GC apparatus at a temperature of 250 °C. The compounds in the hexane solutions were separated using an AT-5MS capillary column with dimensions of 30 m in length and 0.32 mm in diameter and a film thickness of 0.25 µm. The separation conditions were as follows: an initial temperature of 40 °C was maintained for two minutes, after which a temperature increase to 250 °C was initiated at a rate of 4 °C per minute, followed by an additional increase to 300 °C at a rate of 10 °C per minute, where it was maintained for five minutes. The mobile phase was helium 6.0, with a 1.92 mL/min flow rate. The interface temperature was set to 250 °C, while the ion source temperature was maintained at 210 °C. The separated compounds were identified through mass spectrometry, utilising MS scan mode acquisition (35–500 m/z) and the NIST database, while their quantification was performed using the normalised area method. The sample was injected in triplicate. A concordance of at least 90% was observed between the detected compounds and the database. The results were presented as a percentage of the total compounds identified. As previously described, the linear retention index (LRI) was calculated using the normal alkane RI for the same polar column [54].

2.5. Antioxidant Activity by 1,1-Diphenyl-2-Picrylhydrazyl (DPPH) Assay

The antioxidant capacity of the essential oil was assessed using the DPPH method, following the procedure of Floares et al. [22]. A methanolic sample was prepared by dissolving 1 mL of EO in 10 mL of methanol (Sigma–Aldrich; Merck KGaA, Darmstadt, Germany), and the extracts were stored at 2–4 °C until analysis. Different concentrations (2.00, 4.00, 6.67, 10.00, and 20.00 mg/mL) were prepared by diluting the base extract. For each dilution, 3 mL was mixed with 1 mL of 0.3 mM DPPH (Sigma-Aldrich, Taufkirchen, Germany) solution and incubated for 30 min in the dark. The absorbance of the samples was measured at 517 nm using a UV–VIS spectrophotometer (Specord 205; Analytik Jena AG, Jena, Germany). Each sample was tested in triplicate, and the average was recorded.
A control sample was analysed simultaneously, in which the extract was replaced with methanol, while maintaining the same volume and concentration of DPPH solution. Ascorbic acid (0.006–0.016 mg/mL in methanol) from Sigma-Aldrich; Merck KGaA (Darmstadt, Germany) was used as a positive control.
The antioxidant activity was determined as the percentage of radical scavenging activity (RSA) using the following Formula (1):
RSA ( % ) = ( A control A sample A control ) × 100
where Acontrol = the absorbance value of the control sample, and Asample = the absorbance value of the essential oil sample.
The antioxidant capacity of the sample was expressed as the IC50 value and was compared to ascorbic acid.

2.6. Evaluation of the Antimicrobial Activity

In this study, the antimicrobial activity of SNEO was evaluated using a broth microdilution method against a range of Gram-positive and Gram-negative ATCC strains. The selection of bacterial and fungal strains in this study was guided by several important considerations. The inclusion of both Gram-positive and Gram-negative bacteria enables the evaluation of the broad-spectrum antimicrobial potential of S. nigra essential oil. This accounts for the structural and physiological differences between these bacterial groups, which can influence their susceptibility to natural antimicrobial agents. The bacterial strains include both common nosocomial pathogens (Pseudomonas aeruginosa, Staphylococcus aureus) and foodborne pathogens (Listeria monocytogenes, Salmonella typhimurium), covering various ecological niches and infection sources. The inclusion of Clostridium perfringens represents the anaerobic pathogens, broadening the scope of the study. Testing Candida albicans and Candida parapsilosis addresses the potential antifungal properties of SNEO, targeting two fungal species often implicated in opportunistic infections. The Gram-positive ATCC strains included Streptococcus pyogenes (ATCC 19615), Staphylococcus aureus (ATCC 25923), C. perfringens (ATCC 13124), Listeria monocytogenes (ATCC 19114), and Bacillus cereus (ATCC 10876). The Gram-negative strains tested were Pseudomonas aeruginosa (ATCC 27853), Shigella flexneri (ATCC 12022), Escherichia coli (ATCC 25922), Salmonella typhimurium (ATCC 14028), and Haemophilus influenzae tip B (ATCC 10211). Two Candida species were selected as fungal representatives: Candida parapsilopsis (ATCC 22019) and Candida albicans (ATCC 10231). All ATCC strains were sourced from the culture collection of the Laboratory of Microbiology at the Interdisciplinary Research Platform, King Michael I University of Life Sciences, Timisoara.
Following a method described in prior research [1,3], a stock solution of each essential oil was prepared in dimethyl sulfoxide (DMSO). To perform the test, 50 µL of the stock solution was added to 100 µL of a freshly prepared bacterial suspension, standardized to McFarland standard optical density of 0.5 (1.5 × 108 CFU/mL), followed by serial dilutions.
SNEO was tested at concentrations of 0.1 mg/mL, 0.125 mg/mL, 0.25 mg/mL, 0.5 mg/mL, 1 mg/mL, 2 mg/mL, 4 mg/mL, 8 mg/mL, 16 mg/mL, and 32 mg/mL. A bacterial culture in brain heart infusion (BHI) broth, without the essential oil, served as the positive control.
The minimum inhibitory concentration (MIC), defined as the lowest concentration at which no visible bacterial growth was observed, was determined spectrophotometrically by measuring the optical density [1,2,3]. The results were interpreted by calculating two indicators, bacterial growth rate (BGR) and bacterial inhibition rate (BIR), using Formulas (2) and (3), as follows:
BGR = ODsample/ODnegative control × 100 (%)
BIR = 100 − BGR (%)
* where ODsample refers to the optical density of the sample, which contains a specific type and concentration of essential oils being tested, measured at 540 nm as the average of triplicate readings, and ODnegative control represents the optical density at 540 nm, calculated as the average of triplicate readings for the selected bacteria in BHI broth.

2.7. Molecular Docking Studies

PyRx-Python Prescription 0.8 was used in the docking assessment between the most abundant compounds (≥1%) identified in SNEO and the antimicrobial and antioxidant protein targets (PDB ID: 1JIK, 6G9S, 8JZN, 3DRA, 2CAG, 2P31). The SDF formats of the compounds were downloaded from https://pubchem.ncbi.nlm.nih.gov/ (accessed on 9 November 2024) [55], while the PDB formats of the proteins were retrieved from https://www.rcsb.org/ (accessed on 8 November 2024) [56].
The coordinates of the grid box, as presented in Table 1, were applied to commence the docking of the compounds and each of the proteins. Post-docking analysis was performed in Discovery Studio Visualizer v21.1.0.20298 (BIOVIA, San Diego, CA, USA), which allowed for the 3D and 2D visualisation of the binding interactions. The ligand–protein interactions involving hydrophobic and hydrophilic bonds were collected and used to establish the predictable pharmacological profile between the compounds of high abundance and the respective microbial proteins.

2.8. Statistical Analysis

Statistical analysis was carried out using JASP 0.19. Descriptive statistics, including the mean and standard deviation, were computed to assess the study data. Group comparisons were performed using analysis of variance (ANOVA), followed by Tukey’s post hoc test. A significance level of p < 0.05 was considered statistically significant.

3. Results

3.1. Fatty Acid Profile

Subsequent to a Soxhlet extraction with a yield (w/v) of 1.46 ± 0.08, the GC–MS analysis identified ten fatty acids in the crude fat extracted from elderflower, seven being saturated fatty acids and representing 45% of the total (Table 2).

3.2. GC–MS Volatile Compounds Profile

The essential oil obtained produced an oil yield of (w/v): 0.14 ± 0.01%, and the GC–MS analysis revealed 25 compounds, representing chemical constituents present by more than 0.5% in the composition of SNEO, as detailed in Table 3.

3.3. Antioxidant Capacity by 1,1-Diphenyl-2-Picrylhydrazyl (DPPH) Assay

Antioxidant activity represents a fundamental biological property with significant implications for various industries, including cosmetics, food, and beverages. Since antioxidant potential is a critical measure for determining the therapeutic advantages of plants, antioxidant assays were employed in this study, specifically the radical scavenging (DPPH) method. This specific assay is frequently recommended due to its simplicity, rapidity, reproducibility, and cost-effectiveness, which collectively make it an optimal tool for evaluating the antioxidant activity of plants.
To assess the radical scavenging activity using the DPPH method, five concentrations (20.00 mg/mL, 10.00 mg/mL, 6.67 mg/mL, 4.00 mg/mL, and 2.00 mg/mL) of essential oil dissolved in methanol were prepared from the three samples tested. At the same time, the antioxidant activity of five ascorbic acid solutions at varying concentrations (0.006–0.016 mg/mL) was measured as a positive control, with the highest concentration (0.016 mg/mL) exhibiting 91.13% inhibition (Table 3).
The IC50 was calculated and expressed in mg/mL (Table 4). The IC50 is the concentration of essential oil required to induce 50% DPPH inhibition.
The results are presented as the mean of three determinations ± standard deviation (SD).
The percentage of DPPH inhibition was 85.38% at 20 mg/mL, 82.47% at 10 mg/mL, 69.81% at 6.67 mg/mL, 37.97% at 4 mg/mL, and 17.61% at 2 mg/mL.
As shown in Table 4, the highest concentration (20 mg/mL) exhibited the maximum radical scavenging activity.
The percentage of DPPH inhibition remained elevated at two lower concentrations (10 mg/mL and 6.67 mg/mL). However, it decreased significantly at the lowest concentration tested (2 mg/mL).
As shown in Table 5, the IC50 value for SN is lower than that of ascorbic acid, suggesting that SN may offer more significant protection against oxidation. Statistical analysis indicated no significant difference between ascorbic acid and SN essential oil (p = 0.927), suggesting that the antioxidant effect of SN essential oil may be comparable to that of ascorbic acid.

3.4. Evaluation of the Antimicrobial Activity

Table 6 presents the antimicrobial activity of SNEO against ATCC strains, including Gram-positive bacteria, and Table 7 shows the activity against Gram-negative bacteria and two fungal Candida strains.
In evaluating the antibacterial activity of SNEO against Gram-positive bacteria (Table 6), the efficacy was generally low, as the inhibition rates were negative across all strains tested. However, S. pyogenes, S. aureus, and C. perfringens displayed an ascending trend in regards to antibacterial activity, with inhibition positively correlated to increased oil concentrations. The MIC values for these strains were 0.25 mg/mL for C. perfringens, 0.5 mg/mL for S. pyogenes, and 1 mg/mL for S. aureus. In contrast, the activity of SNEO against L. monocytogenes and B. cereus showed no positive inhibition trend. Instead, the bacterial inhibition rate (BIR%) decreased as the concentration increased, resulting in a strain-boosting effect, an effect demonstrated by a bacterial growth rate higher by 50% compared to the strain unaffected by the oil activity. Compared to the untreated strains, L. monocytogenes showed a negative inhibition rate of −47.38%, and B. cereus showed an even greater negative inhibition rate of −57.79%, indicating a growth-promoting effect at higher oil concentrations.
The following table represents the antimicrobial inhibitory activity of SNEO against different microbial strains, expressed as percentage inhibition, at various concentrations of mg/mL, along with their IC50 values.
In most cases, the inhibition is concentration-dependent, that is to say, an enhanced SNEO concentration results in higher antimicrobial activity; on the other hand, some strains, for example, S. flexneri and P. aeruginosa, exhibit negative percent values at high concentrations. SNEO shows moderate activity against P. aeruginosa, where the inhibition percentage is reduced with an increase in concentration. The IC50 value is 11.73 mg/mL; hence, it is moderately susceptible. The IC50 value for S. flexneri is 9.65 mg/mL, which reveals that it has better sensitivity than does P. aeruginosa. Inhibition increases in a dose-dependent manner. Regarding E. coli, the strain presented an intermediate sensitivity, with an IC50 value of 2.90 mg/mL; however, SNEO showed potent inhibition at concentrations much lower than the respective IC50, indicating a strain-boosting effect. The strains of S. typhimurium and H. influenzae are moderately susceptible, with IC50 values of 8.85 and 8.72 mg/mL, respectively. The inhibition is dose-dependent but much less pronounced than that for E. coli. SNEO exhibits potent activity against C. parapsilosis, with an IC50 value of 12.07 mg/mL. C. albicans is the most sensitive tested organism, with an IC50 value of 3.08 mg/mL. Inhibition is high even at the lowest concentration tested (73.78% at 0.1 mg/mL), suggesting an exceptional antifungal potency. SNEO exhibits more activity against fungal strains, especially C. albicans, than against bacterial strains, which might be attributed to differences in the composition and permeability of the cell wall between fungi and bacteria. Among the bacteria, E. coli is the most susceptible to SNEO, while P. aeruginosa shows moderate resistance, in agreement with its known stronger membrane structure and efflux mechanisms.

3.5. Molecular Docking

In the present study, Table 8 showed a keen docking association between the macromolecular targets involved in defining new antibacterial agents, representing attractive target enzymes for antioxidant activity, as put forth by the identified compounds in SNEO. The molecular docking score of the protein–ligand revealed interesting binding energies ranging from −7.0 to −3.2 kcal/mol, indicating the relative binding affinity in the docked complex. Accordingly, the current study showed cis-rose oxide (−5.3 kcal/mol with 1JIK; −6.0 kcal/mol with 8JZN), nonanal (−4.4 kcal/mol with 6G9S; −4.8 kcal/mol with 8JZN; -4.6 kcal/mol with 3DRA; −4.9 kcal/mol with 2CAG; −3.5 kcal/mol with 2P31), 2-Pentadecanone, 6,10,14-trimethyl- (−7.0 kcal/mol with 2CAG), and tans-rose oxide (−6.2 kcal/mol with 2CAG) exhibited predictable binding to the pockets of the respective protein targets (Figure 1).
In the binding site of tyrosyl-tRNA synthetase, cis-rose oxide was involved in hydrogen bonding (His50), carbon–hydrogen bonding (Ile103), and other alkyl–hydrophobic bonding (Figure 1a). Similarly, nonanal was observed to occupy the penicillin-binding protein 2 binding pocket in hydrogen-bonding (His203, Asp204) and alkyl interactions (Arg68, Lys162, Val179). At the same time, cis-rose oxide showed a carbon–hydrogen bond (Pro66) and other alkyl bonds with the same protein (Figure 1b,c). As for the binding complex of catalase, 2-Pentadecanone, 6,10,14-trimethyl- was observed to display a hydrogen-bond interaction (Arg52, Omt53), nonanal had hydrogen-bond interaction (Ser93), carbon-hydrogen bond (Gly110); trans-rose oxide was also involved in hydrogen-bonding (Arg51), all of which were among alkyl and sigma hydrophobic bonds (Figure 1d–f). Furthermore, in the binding pattern of glutathione peroxidase, nonanal showed hydrogen-bonding interaction (Asn32) and other alkyl/sigma hydrophobic bonds (Figure 1g). Additionally, the possible interactions between 1,3-β-glucan synthase and nonanal are hydrogen-bond formations (His1654), among other hydrophobic alkyl and pi–alkyl bonds; likewise cis-rose oxide interacts with the protein in both hydrogen (Arg1182), carbon–hydrogen (Gln1376), and other hydrophobic bonds (Figure 1h,i). The best binding geometry of protein geranylgeranyltransferase-I was recorded with nonanal, involving hydrogen bonds with two amino acid residues (Tyr163, Thr375) and four alkyl–/pi–alkyl bonds (Figure 1j).

4. Discussion

The chemical composition of Sambucus nigra L. varies due to several factors, including climatic conditions, geographic location, cultivar, ripening stage, and the specific part of the plant [7,28,29]. Additionally, the various extraction methods can also produce different chemical profiles from natural products [7,22,38]. Knowing that chemical compounds determine biological properties, it is crucial to analyse the obtained natural products thoroughly. Regarding Sambucus nigra L. essential oil (SNEO), only a few studies described its compounds and biological aspects, especially the antioxidant properties [28,29].
Among the chemical compounds of SN oil, the fatty acids are presented in different concentrations and varying principal compounds. Szymański et al. [28] reported a total % of fatty acids and derivatives of 9.14%, with palmitic acids as the main compound (43.47%). Instead, the SN oil from the present study is dominated by oleic acid (32.806%), a monounsaturated fatty acid (MUFA). Oleic acid has been primarily recognised for its anti-inflammatory and cardioprotective effects, attributed to its ability to regulate cholesterol levels and promote vascular function [57,58,59,60]. Other fatty acids, such as linolenic acid (12.794%) and linoleic acid (9.397%), represent the major PUFA (polyunsaturated fatty acids) components producing the oil’s antioxidant and anti-inflammatory properties [61,62,63]. Moreover, the studied SN oil contains a significant concentration of palmitic acid (26.574%), a saturated fatty acid (SFA) that enhances oil stability and plays a crucial role as a fundamental element in energy storage and skin barrier integrity [64,65,66,67]. Other SFAs, such as stearic acid (3.996%) and lignoceric acid (4.554%), contribute to the moisturising and emollient characteristics, making it useful for cosmetic applications [68]. A high amount of saturated fatty acids (45.002%) provides structural stability, while the monounsaturated (32.806%) and polyunsaturated fatty acids (22.191%) perhaps explain part of the biological activities. These results present the balance of the SN oil components.
The GC–MS profile of elderflower essential oils reveals different bioactive compounds in various concentrations. Vujavonic et al. [29] showed that the essential oil obtained from the traditionally dried elderflower contained carane as a major compound (13.91%), followed by α-limonene diepoxide (7.23%), methyl salicylate (7%), and caryophyllene (6.55%). Szymański et al. [28] demonstrated that the essential oils are dominated by tritetracontane (20.237%). Other principal compounds included 2-Methyl-3,13-octadecadienoic (5.438%), 9,10-Epoxyoctadecan-1-ol (4.202%), and rose oxide (3.089%) [28]. Our research demonstrated that the most abundant compounds were alkanes (74.59%), heneicosane (25.08%), and nonadecane (23.19%). Other significant constituents include tetracosane (9.35%) and heptadecane (7.96%). The alkanes are known for their potential role in enhancing the stability of oils due to their hydrophobic interactions [69,70]. Among the terpenes class, cis-rose oxide (3.87%), trans-rose oxide (1.74%), and β-Linalool (1.56%) were distinguished. These results are similar to those demonstrated by Szymański et al. [28], which showed that rose oxide was the main compound in the monoterpenes group. It is well documented that the biological properties of oxygenated and alcohol terpenes consist of high antimicrobial and antioxidant activities, likely attributed to their interaction with microbial enzymes and their mechanisms of oxidation [3,71,72,73,74].
The potential of elderflower extract as an antioxidant has attracted considerable attention, leading to numerous investigations into its effectiveness [20,23,26,27,36,38]. However, the antioxidant properties of the essential oil obtained from the flowers have not been extensively researched until now. The present study highlighted that SNEO had an IC50 value of 2.520 mg/mL, similar to that obtained using ascorbic acid. Similar values (225.40 µL/mL) were also noted by Szymański et al. [28] when they studied the essential oil obtained from Sambucus nigra L. flowers via hydrodistillation, using essential oil from Matricaria recutita flowers as a positive control (90.78 µL/mL).
In terms of antimicrobial properties, various extracts of Sambucus nigra L. have been shown to exhibit strong antibacterial activity against both Gram-positive and Gram-negative bacteria [31,36,37,38] but also against various classes of fungus [30,44]. To our knowledge, this is the first study regarding SNEO antimicrobial activity. According to our results, all the Gram-positive bacterial strains were sensitive to SNEO, with IC50 values between 1.93 mg/mL and 10.40 mg/mL. The essential oil showed moderate activity against S. pyogenes (IC50 = 10.40 mg/mL) and S. aureus (IC50 = 9.84 mg/mL), with a positive trend as the concentration grew. Also, C. perfringens presented a moderate sensitivity to SNEO, with an IC50 of 8.92 mg/mL. L. monocytogenes was the most sensitive bacteria to the SNEO, while S. aureus was the most resistant, requiring a 1 mg/mL concentration to inhibit its growth. Compared to Gram-positive bacteria, Gram-negative bacteria were more resistant, with IC values between 2.90 mg/mL and 11.73 mg/mL. This can be explained by the difference in the cell envelope structure between the two groups of bacteria. The Gram-negative type contained an outer lipopolysaccharide membrane [75]. Of all the studied Gram-negative bacteria, E. coli was the most sensitive (IC50-2.90 mg/mL). The antifungal activity of SNEO was evident, especially against C. albicans, the most sensitive fungal culture, with a MIC value of 0.1 mg/mL and an IC50 of 3.08 mg/mL.
SNEO revealed a dose-dependent increase in antimicrobial activity, which means that it exhibits increased activity at higher concentrations. The broad-spectrum efficacy of SNEO is attributed to its chemical compounds, whose mechanisms of action are entirely elucidated. The high content of fatty acids, such as palmitic acid and oleic acid, may disrupt microbial cell membrane integrity. Still, it has been demonstrated to promote membrane fluidity, which can facilitate microbial cell lysis [76,77,78,79]. A similar effect seems to be attributed to nonanal and rose oxides. Cis- and trans-rose oxides have been reported to exhibit strong antifungal and antibacterial effects, likely through interactions with microbial enzymes and membrane structures [80]. Similarly, β-Linalool (1.56%), a terpene alcohol, is known for its antimicrobial and anti-inflammatory activity achieved through membrane disruption by inhibiting the expression of the inflammatory pathways [81,82,83]. This indicates that the oil’s antimicrobial activity results from the synergistic action of more than one compound.
The results demonstrated in Table 8 clearly show that both nonanal and cis-rose oxide interact better with the four protein targets, showing differential binding energies and complex formation. Moreover, it is interesting to predict how these compounds could potentially contribute to the multiple functions of SN in serving as antimicrobial and antioxidant therapeutic agents. Tyrosyl–tRNA synthetase possesses a binding pocket delineated by the amino acid residues Ala37, Asp38, Thr40, Ala41, Ser43, Leu44, His48, and Ile101 [84]. Nonanal exploits the amino acids within this region to exert both polar (His50) and non-polar (alkyl-typed hydrophobic bonds) with this protein (Figure 1a). Both nonanal and cis-rose oxide exhibited hydrophilic solid and hydrophobic interactions with penicillin-binding protein 2 (Figure 1b,c) and 1,3-β-glucan synthase (Figure 1g,h), thus potentially exercising inhibition of bacterial and fungal cell wall synthesis, thereby halting wall formation and ultimately leading to the death of the bacteria and fungi [80]. Virulence microorganisms have been reported to use catalase and glutathione peroxidase to detoxify reactive oxygen species, which is increased by the phagocytotic pathway [83,84]. Interestingly, similar to the results of other studies, the docking study revealed mechanistic insight into how 2-Pentadecanone, 6,10,14-trimethyl-, trans-rose oxide, and nonanal inhibits these antioxidant enzymes (Figure 1d–g). The protein prenylation pathway is important for the post-translation lipid modification of key cellular proteins in fungi, and arresting this process is central to limiting their infection to humans [85]. Therefore, in this study, nonanal is shown to possess strong potential binding sites for protein geranylgeranyltransferase-I (Figure 1j) in comparison to other identified compounds in SNEO. Provisionally, understanding the inhibitory potential of the compounds is supported by their strong and equally binding interaction with key protein targets crystallized from microorganisms similar to those utilized in determining the antimicrobial and antioxidant potential of the SNEO in vitro.

5. Conclusions

The present study showed the bioactive characteristics of Sambucus nigra oil, revealing a balanced composition and major biological activities. Fatty acid analysis showed a profile mainly composed of oleic acid (32.8%), palmitic acid (26.6%), and linolenic acid (12.8%), which confirmed its stability and functional properties. GC–MS identified the presence of volatile compounds such as nonanal (4.36%), cis-rose oxide (3.87%), and trans-rose oxide (1.74%), which are known for their antimicrobial and antioxidant roles in SNEO. Antioxidant activity, by means of DPPH radical scavenging, showed significant inhibition at an IC50 value equivalent to 2.52 mg/mL—comparable to that of ascorbic acid. The antimicrobial activity was assayed to show moderate inhibitory effects, with C. albicans being the most sensitive (IC50 = 3.08 mg/mL), followed by E. coli (IC50 = 2.90 mg/mL). While the Gram-negative bacteria generally revealed a higher extent of resistance, S. pyogenes and S. aureus showed moderate susceptibility at high concentrations. These results were complemented by molecular docking studies, which revealed strong interactions between key volatile compounds, such as nonanal and cis-rose oxide, and microbial proteins. Such interactions could inhibit cell wall synthesis and the enzymatic activity necessary for microbial viability.
This research finding opens the therapeutic window for the use of SNEO as a natural antimicrobial and antioxidant agent. Its efficacy against fungal strains, specifically C. albicans, along with its antioxidant features, suggests a range of uses in treating microbial infections and oxidative stress. Future research should be directed at the practical applications of this compound, including clinical trials and formulation development, and its importance in sustainable agriculture and alternative medicine.

Author Contributions

Conceptualisation, D.F., D.O., A.H., M.A.S. and I.P.; methodology, D.F., D.O., A.H., M.A.S. and I.P.; software, D.F., D.O., A.H., M.A.S. and I.P.; validation, D.F., D.O., A.H., M.A.S. and I.P.; formal analysis, D.F., D.O., A.H., M.A.S., I.P., A.B., I.S. and I.R.; investigation, D.F., D.O., A.H., M.A.S., I.P., A.B., I.S. and I.R.; writing—original draft preparation, D.F., D.O., A.H., M.A.S., I.P., A.B., I.S. and I.R.; writing—review and editing, D.F., D.O., A.H., M.A.S., I.P. and I.R.; visualisation, D.F., D.O., A.H., M.A.S., I.P., A.B., I.S. and I.R.; supervision, D.F., D.O., A.H. M.A.S., I.P. and I.R.; funding acquisition, I.R. All authors have read and agreed to the published version of the manuscript.

Funding

This study is supported by the King Michael I University of Life Sciences, Timisoara.

Data Availability Statement

The report of the analysis performed for the samples in the paper can be found at the Interdisciplinary Research Platform (PCI) belonging to the King Michael I University of Life Sciences, Timisoara.

Acknowledgments

We have carried out this study with the support of the Interdisciplinary Research Platform belonging to the King Michael I University of Life Sciences, Timisoara, where all the analyses were conducted.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Bălașoiu (Jigău), R.A.C.; Obistioiu, D.; Hulea, A.; Suleiman, M.A.; Popescu, I.; Floares (Oarga), D.; Imbrea, I.M.; Neacșu, A.-G.; Șmuleac, L.; Pașcalău, R.; et al. Analysing the Antibacterial Synergistic Interactions of Romanian Lavender Essential Oils via Gas Chromatography–Mass Spectrometry: In Vitro and In Silico Approaches. Plants 2024, 13, 2136. [Google Scholar] [CrossRef]
  2. Dégi, J.; Herman, V.; Igna, V.; Dégi, D.M.; Hulea, A.; Muselin, F.; Cristina, R.T. Antibacterial Activity of Romanian Propolis against Staphylococcus aureus Isolated from Dogs with Superficial Pyoderma: In Vitro Test. Vet. Sci. 2022, 9, 299. [Google Scholar] [CrossRef]
  3. Obiștioiu, D.; Hulea, A.; Cocan, I.; Alexa, E.; Negrea, M.; Popescu, I.; Herman, V.; Imbrea, I.M.; Heghedus-Mindru, G.; Suleiman, M.A.; et al. Boswellia Essential Oil: Natural Antioxidant as an Effective Antimicrobial and Anti-Inflammatory Agent. Antioxidants 2023, 12, 1807. [Google Scholar] [CrossRef] [PubMed]
  4. Beicu, R.; Alexa, E.; Obiștioiu, D.; Cocan, I.; Imbrea, F.; Pop, G.; Circioban, D.; Moisa, C.; Lupitu, A.; Copolovici, L.; et al. Antimicrobial Potential and Phytochemical Profile of Wild and Cultivated Populations of Thyme (Thymus sp.) Growing in Western Romania. Plants 2021, 10, 1833. [Google Scholar] [CrossRef]
  5. Han, K.-T.; Ruan, L.-W.; Liao, L.-S. Effects of Indoor Plants on Human Functions: A Systematic Review with Meta-Analyses. Int. J. Environ. Res. Public Health 2022, 19, 7454. [Google Scholar] [CrossRef]
  6. Rodrigues, S.; De Brito, E.S.; De Oliveira Silva, E. Elderberry— Sambucus nigra L. In Exotic Fruits; Elsevier: Amsterdam, The Netherlands, 2018; pp. 181–185. ISBN 978-0-12-803138-4. [Google Scholar]
  7. Młynarczyk, K.; Walkowiak-Tomczak, D.; Łysiak, G.P. Bioactive Properties of Sambucus nigra L. as a Functional Ingredient for Food and Pharmaceutical Industry. J. Funct. Foods 2018, 40, 377–390. [Google Scholar] [CrossRef]
  8. Fejer, J.; Salamon, I.; Grulova, D.; Michalek, S.; Zvalova, M. Elderberry (Sambucus nigra) cultivation in Slovak Republic and identification and quantification of anthocyanins. Acta Hortic. 2015, 253–258. [Google Scholar] [CrossRef]
  9. Pascariu, O.-E.; Israel-Roming, F. Bioactive Compounds from Elderberry: Extraction, Health Benefits, and Food Applications. Processes 2022, 10, 2288. [Google Scholar] [CrossRef]
  10. Salamon, I.; Mariychuk, R.; Grulova, D. Optimal extraction of pure anthocyanins from fruits of Sambucus nigra. Acta Hortic. 2015, 73–78. [Google Scholar] [CrossRef]
  11. Salamon, I.; Grulova, D. Elderberry (Sambucus nigra): From natural medicine in ancient times to protection against witches in the middle ages—A brief historical overview. Acta Hortic. 2015, 1061, 35–39. [Google Scholar] [CrossRef]
  12. Salamon, I.; Grulova, D.; Hancianu, M.; Cioanca, O. Optimization of lyophilization technology for purification and stabilization of anthocyanins from elderberry fruits. Acta Hortic. 2015, 1061, 245–252. [Google Scholar] [CrossRef]
  13. Festa, J.; Hussain, A.; Hackney, A.; Desai, U.; Sahota, T.S.; Singh, H.; Da Boit, M. Elderberry Extract Improves Molecular Markers of Endothelial Dysfunction Linked to Atherosclerosis. Food Sci. Nutr. 2023, 11, 4047–4059. [Google Scholar] [CrossRef]
  14. Salvador, Â.; Król, E.; Lemos, V.; Santos, S.; Bento, F.; Costa, C.; Almeida, A.; Szczepankiewicz, D.; Kulczyński, B.; Krejpcio, Z.; et al. Effect of Elderberry (Sambucus nigra L.) Extract Supplementation in STZ-Induced Diabetic Rats Fed with a High-Fat Diet. Int. J. Mol. Sci. 2016, 18, 13. [Google Scholar] [CrossRef]
  15. Ma, X.; Ning, S. Cyanidin-3-glucoside Attenuates the Angiogenesis of Breast Cancer via Inhibiting STAT3/VEGF Pathway. Phytother. Res. 2019, 33, 81–89. [Google Scholar] [CrossRef]
  16. Haș, I.M.; Teleky, B.-E.; Szabo, K.; Simon, E.; Ranga, F.; Diaconeasa, Z.M.; Purza, A.L.; Vodnar, D.-C.; Tit, D.M.; Nițescu, M. Bioactive Potential of Elderberry (Sambucus nigra L.): Antioxidant, Antimicrobial Activity, Bioaccessibility and Prebiotic Potential. Molecules 2023, 28, 3099. [Google Scholar] [CrossRef]
  17. Torabian, G.; Valtchev, P.; Adil, Q.; Dehghani, F. Anti-Influenza Activity of Elderberry (Sambucus nigra). J. Funct. Foods 2019, 54, 353–360. [Google Scholar] [CrossRef]
  18. Seymenska, D.; Shishkova, K.; Hinkov, A.; Benbassat, N.; Teneva, D.; Denev, P. Comparative Study on Phytochemical Composition, Antioxidant, and Anti-HSV-2 Activities of Sambucus nigra L. and Sambucus Ebulus L. Extracts. Appl. Sci. 2023, 13, 12593. [Google Scholar] [CrossRef]
  19. Seymenska, D.; Teneva, D.; Nikolova, I.; Benbassat, N.; Denev, P. In Vivo Anti-Inflammatory and Antinociceptive Activities of Black Elder (Sambucus nigra L.) Fruit and Flower Extracts. Pharmaceuticals 2024, 17, 409. [Google Scholar] [CrossRef]
  20. Osman, A.G.; Avula, B.; Katragunta, K.; Ali, Z.; Chittiboyina, A.G.; Khan, I.A. Elderberry Extracts: Characterization of the Polyphenolic Chemical Composition, Quality Consistency, Safety, Adulteration, and Attenuation of Oxidative Stress- and Inflammation-Induced Health Disorders. Molecules 2023, 28, 3148. [Google Scholar] [CrossRef]
  21. Marțiș (Petruț), G.S.; Mureșan, V.; Marc (Vlaic), R.M.; Mureșan, C.C.; Pop, C.R.; Buzgău, G.; Mureșan, A.E.; Ungur, R.A.; Muste, S. The Physicochemical and Antioxidant Properties of Sambucus nigra L. and Sambucus nigra Haschberg during Growth Phases: From Buds to Ripening. Antioxidants 2021, 10, 1093. [Google Scholar] [CrossRef] [PubMed]
  22. Floares (Oarga), D.; Cocan, I.; Alexa, E.; Poiana, M.-A.; Berbecea, A.; Boldea, M.V.; Negrea, M.; Obistioiu, D.; Radulov, I. Influence of Extraction Methods on the Phytochemical Profile of Sambucus nigra L. Agronomy 2023, 13, 3061. [Google Scholar] [CrossRef]
  23. Pascariu, O.-E.; Dias, L.G.; Israel-Roming, F. Optimization of Extraction Method of Bioactive Compounds from Elderberries (Sambucus nigra L.) and Testing Extract Stability. Horticulturae 2024, 10, 743. [Google Scholar] [CrossRef]
  24. Tundis, R.; Ursino, C.; Bonesi, M.; Loizzo, M.R.; Sicari, V.; Pellicanò, T.; Manfredi, I.L.; Figoli, A.; Cassano, A. Flower and Leaf Extracts of Sambucus nigra L.: Application of Membrane Processes to Obtain Fractions with Antioxidant and Antityrosinase Properties. Membranes 2019, 9, 127. [Google Scholar] [CrossRef]
  25. Horablaga, N.M.; Cozma, A.; Alexa, E.; Obistioiu, D.; Cocan, I.; Poiana, M.-A.; Lalescu, D.; Pop, G.; Imbrea, I.M.; Buzna, C. Influence of Sample Preparation/Extraction Method on the Phytochemical Profile and Antimicrobial Activities of 12 Commonly Consumed Medicinal Plants in Romania. Appl. Sci. 2023, 13, 2530. [Google Scholar] [CrossRef]
  26. Ferreira, S.S.; Silva, A.M.; Nunes, F.M. Sambucus nigra L. Fruits and Flowers: Chemical Composition and Related Bioactivities. Food Rev. Int. 2022, 38, 1237–1265. [Google Scholar] [CrossRef]
  27. Qazimi, B.; Stanoeva, J.P.; Cvetanoska, M.; Geskovski, N.; Dragusha, S.; Koraqi, H.; Qazimi, V.; Ejupi, V. Phenolic Compound Composition of Sambucus nigra L. Wild-Growing Plants from Kosovo. Turk. J. Pharm. Sci. 2024, 20, 380–389. [Google Scholar] [CrossRef]
  28. Szymański, M.; Dudek-Makuch, M.; Witkowska-Banaszczak, E.; Bylka, W.; Szymański, A. Comparison of the Chemical Composition and Antioxidant Activity of Essential Oils from the Leaves and Flowers of Sambucus nigra. Pharm. Chem. J. 2020, 54, 496–503. [Google Scholar] [CrossRef]
  29. Vujanovic, M.; Djurovic, S.; Radojkovic, M. Chemical Composition of Essential Oils of Elderberry (Sambucus nigra L.) Flowers and Fruits. Acta Period. Technol. 2021, 52, 229–237. [Google Scholar] [CrossRef]
  30. Sánchez-Hernández, E.; Balduque-Gil, J.; González-García, V.; Barriuso-Vargas, J.J.; Casanova-Gascón, J.; Martín-Gil, J.; Martín-Ramos, P. Phytochemical Profiling of Sambucus nigra L. Flower and Leaf Extracts and Their Antimicrobial Potential against Almond Tree Pathogens. Int. J. Mol. Sci. 2023, 24, 1154. [Google Scholar] [CrossRef] [PubMed]
  31. Baccouri, B.; Rajhi, I. Potential Antioxidant Activity of Terpenes. In Biochemistry; Perveen, S., Mohammad Al-Taweel, A., Eds.; IntechOpen: London, UK, 2021; Volume 21, ISBN 978-1-83881-916-3. [Google Scholar]
  32. Xu, D.-P.; Li, Y.; Meng, X.; Zhou, T.; Zhou, Y.; Zheng, J.; Zhang, J.-J.; Li, H.-B. Natural Antioxidants in Foods and Medicinal Plants: Extraction, Assessment and Resources. Int. J. Mol. Sci. 2017, 18, 96. [Google Scholar] [CrossRef] [PubMed]
  33. Sun, W.; Shahrajabian, M.H. Therapeutic Potential of Phenolic Compounds in Medicinal Plants—Natural Health Products for Human Health. Molecules 2023, 28, 1845. [Google Scholar] [CrossRef] [PubMed]
  34. Dawidowicz, A.L.; Wianowska, D.; Baraniak, B. The Antioxidant Properties of Alcoholic Extracts from Sambucus nigra L. (Antioxidant Properties of Extracts). LWT-Food Sci. Technol. 2006, 39, 308–315. [Google Scholar] [CrossRef]
  35. Viapiana, A.; Wesolowski, M. The Phenolic Contents and Antioxidant Activities of Infusions of Sambucus nigra L. Plant Foods Hum. Nutr. 2017, 72, 82–87. [Google Scholar] [CrossRef] [PubMed]
  36. Mikulic-Petkovsek, M.; Samoticha, J.; Eler, K.; Stampar, F.; Veberic, R. Traditional Elderflower Beverages: A Rich Source of Phenolic Compounds with High Antioxidant Activity. J. Agric. Food Chem. 2015, 63, 1477–1487. [Google Scholar] [CrossRef]
  37. Christensen, L.P.; Kaack, K.; Fretté, X.C. Selection of Elderberry (Sambucus nigra L.) Genotypes Best Suited for the Preparation of Elderflower Extracts Rich in Flavonoids and Phenolic Acids. Eur. Food Res. Technol. 2008, 227, 293–305. [Google Scholar] [CrossRef]
  38. Gentscheva, G.; Milkova-Tomova, I.; Nikolova, K.; Buhalova, D.; Andonova, V.; Gugleva, V.; Petkova, N.; Yotkovska, I.; Ivanova, N. Antioxidant Activity and Chemical Characteristics of Sambucus nigra L. Blossom from Different Regions in Bulgaria. Horticulturae 2022, 8, 309. [Google Scholar] [CrossRef]
  39. Tabaszewska, M.; Sikora, E. The Effect of the Plant Stabilisation Method on the Composition and Antioxidant Properties of Elderflower (Sambucus nigra L.) Extract. Molecules 2023, 28, 2365. [Google Scholar] [CrossRef]
  40. Milkova-Tomova, I.; Kazakova, Z.; Buhalova, D.; Gentscheva, G.; Nikolova, K.; Minkova, S. Antioxidant Properties and Antibacterial Activity of Water Extracts from Sambucus nigra L. under Different Conditions. Folia Medica 2023, 65, 295–300. [Google Scholar] [CrossRef]
  41. Przybylska-Balcerek, A.; Szablewski, T.; Szwajkowska-Michałek, L.; Świerk, D.; Cegielska-Radziejewska, R.; Krejpcio, Z.; Suchowilska, E.; Tomczyk, Ł.; Stuper-Szablewska, K. Sambucus nigra Extracts–Natural Antioxidants and Antimicrobial Compounds. Molecules 2021, 26, 2910. [Google Scholar] [CrossRef] [PubMed]
  42. Goud, N.S.; Prasad, G. Antioxidant, antimicrobial activity and total phenol and flavonoids analysis of Sambucus nigra (elderberry). Int. J. Curr. Pharm. Sci. 2020, 12, 35–37. [Google Scholar] [CrossRef]
  43. Konečná, M.; Sedlák, V.; Tkáčiková, L.; Kšonžeková, P.; Mydlárová-Blaščáková, M.; Gruľová, D.; Gaľová, J.; Gogaľová, Z.; Babejová, A.; Vašková, H.; et al. Пригнічення Рoсту Грамнегативних Бактерій Антoціанами Ягідних Плoдів. Наукoвий Вісник Ужгoрoдськoгo Університету Серія Біoлoгія 2019, 42–47. [Google Scholar] [CrossRef]
  44. Mohammadsadegh, S.; Malekpour, A.; Zahedi, S.; Eskanndari, F. The Antimicrobial Activity of Elderberry (Sambucus nigra L.) Extract against Gram Positive Bacteria, Gram Negative Bacteria and Yeast. Res. J. Appl. Sci. 2013, 8, 240–243. [Google Scholar]
  45. Murthi, K.K.; Smith, S.E.; Kluge, A.F.; Bergnes, G.; Bureau, P.; Berlin, V. Antifungal Activity of a Candida Albicans GGTase I Inhibitor-Alanine Conjugate. Inhibition of Rho1p Prenylation in C. Albicans. Bioorganic Med. Chem. Lett. 2003, 13, 1935–1937. [Google Scholar] [CrossRef]
  46. Zhao, C.R.; You, Z.L.; Chen, D.D.; Hang, J.; Wang, Z.B.; Ji, M.; Wang, L.X.; Zhao, P.; Qiao, J.; Yun, C.H.; et al. Structure of a Fungal 1,3-β-Glucan Synthase. Sci. Adv. 2023, 9, eadh7820. [Google Scholar] [CrossRef] [PubMed]
  47. De Ruysscher, D.; Pang, L.; Mattelaer, C.-A.; Nautiyal, M.; De Graef, S.; Rozenski, J.; Strelkov, S.V.; Lescrinier, E.; Weeks, S.D.; Van Aerschot, A. Phenyltriazole-Functionalized Sulfamate Inhibitors Targeting Tyrosyl- or Isoleucyl-tRNA Synthetase. Bioorganic Med. Chem. 2020, 28, 115580. [Google Scholar] [CrossRef]
  48. Kohanski, M.A.; Dwyer, D.J.; Collins, J.J. How Antibiotics Kill Bacteria: From Targets to Networks. Nat. Rev. Microbiol. 2010, 8, 423–435. [Google Scholar] [CrossRef]
  49. Kostopoulou, O.N. Insights into the Chloramphenicol Inhibition Effect on Peptidyl Transferase Activity, Using Two New Analogs of the Drug. Open Enzym. Inhib. J. 2011, 4, 1–10. [Google Scholar] [CrossRef]
  50. Shi, L.; Fang, R.-Q.; Zhu, Z.-W.; Yang, Y.; Cheng, K.; Zhong, W.-Q.; Zhu, H.-L. Design and Synthesis of Potent Inhibitors of β-Ketoacyl-Acyl Carrier Protein Synthase III (FabH) as Potential Antibacterial Agents. Eur. J. Med. Chem. 2010, 45, 4358–4364. [Google Scholar] [CrossRef]
  51. Di Meo, S.; Reed, T.T.; Venditti, P.; Victor, V.M. Role of ROS and RNS Sources in Physiological and Pathological Conditions. Oxidative Med. Cell. Longev. 2016, 2016, 1245049. [Google Scholar] [CrossRef]
  52. Romanian Pharmacopoeia, Xth ed.; Medical Publishing House Bucharest: Bucharest, Romania, 1993.
  53. Horwitz, W.; Chichilo, P.; Reynolds, H. Official Methods of Analysis of the Association of Official Analytical Chemists; Association of Official Analytical Chemists: Washington, DC, USA, 1970. [Google Scholar]
  54. Babushok, V.I.; Linstrom, P.J.; Zenkevich, I.G. Retention Indices for Frequently Reported Compounds of Plant Essential Oils. J. Phys. Chem. Ref. Data 2011, 40, 043101. [Google Scholar] [CrossRef]
  55. Available online: https://pubchem.ncbi.nlm.nih.gov/ (accessed on 8 November 2024).
  56. Available online: https://www.rcsb.org/ (accessed on 9 November 2024).
  57. Lu, Y.; Zhao, J.; Xin, Q.; Yuan, R.; Miao, Y.; Yang, M.; Mo, H.; Chen, K.; Cong, W. Protective Effects of Oleic Acid and Polyphenols in Extra Virgin Olive Oil on Cardiovascular Diseases. Food Sci. Hum. Wellness 2024, 13, 529–540. [Google Scholar] [CrossRef]
  58. Piccinin, E.; Cariello, M.; De Santis, S.; Ducheix, S.; Sabbà, C.; Ntambi, J.M.; Moschetta, A. Role of Oleic Acid in the Gut-Liver Axis: From Diet to the Regulation of Its Synthesis via Stearoyl-CoA Desaturase 1 (SCD1). Nutrients 2019, 11, 2283. [Google Scholar] [CrossRef]
  59. Shramko, V.S.; Polonskaya, Y.V.; Kashtanova, E.V.; Stakhneva, E.M.; Ragino, Y.I. The Short Overview on the Relevance of Fatty Acids for Human Cardiovascular Disorders. Biomolecules 2020, 10, 1127. [Google Scholar] [CrossRef] [PubMed]
  60. Karacor, K.; Cam, M. Effects of Oleic Acid. Med. Sci. Discov. 2015, 2, 125. [Google Scholar] [CrossRef]
  61. Coniglio, S.; Shumskaya, M.; Vassiliou, E. Unsaturated Fatty Acids and Their Immunomodulatory Properties. Biology 2023, 12, 279. [Google Scholar] [CrossRef] [PubMed]
  62. Islam, F.; Imran, A.; Nosheen, F.; Fatima, M.; Arshad, M.U.; Afzaal, M.; Ijaz, N.; Noreen, R.; Mehta, S.; Biswas, S.; et al. Functional Roles and Novel Tools for Improving-oxidative Stability of Polyunsaturated Fatty Acids: A Comprehensive Review. Food Sci. Nutr. 2023, 11, 2471–2482. [Google Scholar] [CrossRef] [PubMed]
  63. Michalak, A.; Mosińska, P.; Fichna, J. Polyunsaturated Fatty Acids and Their Derivatives: Therapeutic Value for Inflammatory, Functional Gastrointestinal Disorders, and Colorectal Cancer. Front. Pharmacol. 2016, 7, 459. [Google Scholar] [CrossRef]
  64. Carta, G.; Murru, E.; Banni, S.; Manca, C. Palmitic Acid: Physiological Role, Metabolism and Nutritional Implications. Front. Physiol. 2017, 8, 902. [Google Scholar] [CrossRef] [PubMed]
  65. Lin, T.-K.; Zhong, L.; Santiago, J. Anti-Inflammatory and Skin Barrier Repair Effects of Topical Application of Some Plant Oils. Int. J. Mol. Sci. 2017, 19, 70. [Google Scholar] [CrossRef] [PubMed]
  66. Mancini, A.; Imperlini, E.; Nigro, E.; Montagnese, C.; Daniele, A.; Orrù, S.; Buono, P. Biological and Nutritional Properties of Palm Oil and Palmitic Acid: Effects on Health. Molecules 2015, 20, 17339–17361. [Google Scholar] [CrossRef]
  67. Mieremet, A.; Helder, R.; Nadaban, A.; Gooris, G.; Boiten, W.; El Ghalbzouri, A.; Bouwstra, J.A. Contribution of Palmitic Acid to Epidermal Morphogenesis and Lipid Barrier Formation in Human Skin Equivalents. Int. J. Mol. Sci. 2019, 20, 6069. [Google Scholar] [CrossRef] [PubMed]
  68. Pereira-Leite, C.; Bom, M.; Ribeiro, A.; Almeida, C.; Rosado, C. Exploring Stearic-Acid-Based Nanoparticles for Skin Applications—Focusing on Stability and Cosmetic Benefits. Cosmetics 2023, 10, 99. [Google Scholar] [CrossRef]
  69. Gayathri, V.R.; Prakash, B.; Yashika, J.V.; Selvi, S.V.; Kumar, D.J. Molecular Docking Analysis of Long-Chain Alkanes with the β-Lactamase BEL-1 from P. aeruginosa. Bioinformation 2022, 18, 460–463. [Google Scholar] [CrossRef]
  70. Faridha Begum, I.; Mohankumar, R.; Jeevan, M.; Ramani, K. GC–MS Analysis of Bio-Active Molecules Derived from Paracoccus Pantotrophus FMR19 and the Antimicrobial Activity Against Bacterial Pathogens and MDROs. Indian J. Microbiol. 2016, 56, 426–432. [Google Scholar] [CrossRef] [PubMed]
  71. Badawy, M.E.I.; Marei, G.I.; Rabea, E.I.; Taktak, N.E.M. Antimicrobial and Antioxidant Activities of Hydrocarbon and Oxygenated Monoterpenes against Some Foodborne Pathogens through in Vitro and in Silico Studies. Pestic. Biochem. Physiol. 2019, 158, 185–200. [Google Scholar] [CrossRef] [PubMed]
  72. Marchese, A.; Arciola, C.; Barbieri, R.; Silva, A.; Nabavi, S.; Tsetegho Sokeng, A.; Izadi, M.; Jafari, N.; Suntar, I.; Daglia, M.; et al. Update on Monoterpenes as Antimicrobial Agents: A Particular Focus on p-Cymene. Materials 2017, 10, 947. [Google Scholar] [CrossRef] [PubMed]
  73. Zengin, H.; Baysal, A. Antibacterial and Antioxidant Activity of Essential Oil Terpenes against Pathogenic and Spoilage-Forming Bacteria and Cell Structure-Activity Relationships Evaluated by SEM Microscopy. Molecules 2014, 19, 17773–17798. [Google Scholar] [CrossRef] [PubMed]
  74. Cadariu, A.I.; Cocan, I.; Negrea, M.; Alexa, E.; Obistioiu, D.; Hotea, I.; Radulov, I.; Poiana, M.-A. Exploring the Potential of Tomato Processing Byproduct as a Natural Antioxidant in Reformulated Nitrite-Free Sausages. Sustainability 2022, 14, 11802. [Google Scholar] [CrossRef]
  75. Rajagopal, M.; Walker, S. Envelope Structures of Gram-Positive Bacteria. In Protein and Sugar Export and Assembly in Gram-positive Bacteria; Bagnoli, F., Rappuoli, R., Eds.; Current Topics in Microbiology and Immunology; Springer International Publishing: Cham, Switzerland, 2015; Volume 404, pp. 1–44. ISBN 978-3-319-56012-0. [Google Scholar]
  76. Guimarães, A.; Venâncio, A. The Potential of Fatty Acids and Their Derivatives as Antifungal Agents: A Review. Toxins 2022, 14, 188. [Google Scholar] [CrossRef]
  77. Pinto, M.E.A.; Araújo, S.G.; Morais, M.I.; Sá, N.P.; Lima, C.M.; Rosa, C.A.; Siqueira, E.P.; Johann, S.; Lima, L.A.R.S. Antifungal and Antioxidant Activity of Fatty Acid Methyl Esters from Vegetable Oils. An. Acad. Bras. Ciênc. 2017, 89, 1671–1681. [Google Scholar] [CrossRef]
  78. Ivanova, E.P.; Nguyen, S.H.; Guo, Y.; Baulin, V.A.; Webb, H.K.; Truong, V.K.; Wandiyanto, J.V.; Garvey, C.J.; Mahon, P.J.; Mainwaring, D.E.; et al. Bactericidal Activity of Self-Assembled Palmitic and Stearic Fatty Acid Crystals on Highly Ordered Pyrolytic Graphite. Acta Biomater. 2017, 59, 148–157. [Google Scholar] [CrossRef]
  79. Padmini, N.; Rashiya, N.; Sivakumar, N.; Kannan, N.D.; Manjuladevi, R.; Rajasekar, P.; Prabhu, N.M.; Selvakumar, G. In Vitro and in Vivo Efficacy of Methyl Oleate and Palmitic Acid against ESBL Producing MDR Escherichia Coli and Klebsiella Pneumoniae. Microb. Pathog. 2020, 148, 104446. [Google Scholar] [CrossRef] [PubMed]
  80. Marinho, A.M.D.R.; De Oliveira, C.M.S.C.; Silva-Silva, J.V.; De Jesus, S.C.A.; Siqueira, J.E.S.; De Oliveira, L.C.; Auzier, J.F.; Soares, L.N.; Pinheiro, M.L.B.; Silva, S.C.; et al. Antimicrobial Activity and Molecular Docking Studies of the Biotransformation of Diterpene Acanthoic Acid Using the Fungus Xylaria sp. Antibiotics 2023, 12, 1331. [Google Scholar] [CrossRef] [PubMed]
  81. Guo, F.; Chen, Q.; Liang, Q.; Zhang, M.; Chen, W.; Chen, H.; Yun, Y.; Zhong, Q.; Chen, W. Antimicrobial Activity and Proposed Action Mechanism of Linalool Against Pseudomonas Fluorescens. Front. Microbiol. 2021, 12, 562094. [Google Scholar] [CrossRef] [PubMed]
  82. Gao, Z.; Van Nostrand, J.D.; Zhou, J.; Zhong, W.; Chen, K.; Guo, J. Anti-Listeria Activities of Linalool and Its Mechanism Revealed by Comparative Transcriptome Analysis. Front. Microbiol. 2019, 10, 2947. [Google Scholar] [CrossRef]
  83. Liu, X.; Cai, J.; Chen, H.; Zhong, Q.; Hou, Y.; Chen, W.; Chen, W. Antibacterial Activity and Mechanism of Linalool against Pseudomonas Aeruginosa. Microb. Pathog. 2020, 141, 103980. [Google Scholar] [CrossRef] [PubMed]
  84. Qiu, X.; Janson, C.A.; Smith, W.W.; Green, S.M.; McDevitt, P.; Johanson, K.; Carter, P.; Hibbs, M.; Lewis, C.; Chalker, A.; et al. Crystal Structure of Staphylococcus aureus tyrosyl-tRNA Synthetase in Complex with a Class of Potent and Specific Inhibitors. Protein Sci. 2001, 10, 2008–2016. [Google Scholar] [CrossRef]
  85. Hast, M.A.; Beese, L.S. Structure of protein geranylgeranyltranferase-I from the human pathogen Candida albicans complexed with a lipid substrate. J. Biol. Chem. 2008, 283, 31933–31940. [Google Scholar] [CrossRef]
Figure 1. The represented 3D and 2D molecular docking results of the active compounds with known microbial proteins (PDB ID: 1JIK, 6G9S, 2CAG, 2P31, 8JZN, 3DRA) as visualised in Discovery studio.
Figure 1. The represented 3D and 2D molecular docking results of the active compounds with known microbial proteins (PDB ID: 1JIK, 6G9S, 2CAG, 2P31, 8JZN, 3DRA) as visualised in Discovery studio.
Agronomy 15 00310 g001aAgronomy 15 00310 g001bAgronomy 15 00310 g001c
Table 1. Binding interaction coordinates for the proteins in the molecular docking.
Table 1. Binding interaction coordinates for the proteins in the molecular docking.
S/NoProteinsPDB IDInteraction Coordinates
1Tyrosyl-tRNA synthetase1JIKCenter X: 34.9074, Y: 11.9032, Z: 89.6565
Dimensions (Angstrom) X: 69. 6981, Y: 43.8698, Z: 51.0095
2Penicillin-binding protein 26G9SCenter X: 29.4505, Y: 55.2099, Z: 39.0797
Dimensions (Angstrom) X: 82.3524, Y: 88.9743, Z: 52.0756
3Catalase2CAGCenter X: 63.3670, Y: 18.0277, Z: 16.2820
Dimensions (Angstrom) X: 63.6866, Y: 77.0070, Z: 90.1406
4Glutathione peroxidase2P31Center X: −8.2367, Y: −0.6748, Z: −23.6360
Dimensions (Angstrom) X: 37.8548, Y: 34. 5011, Z: 79.1468
51,3-β-glucan synthase8JZNCenter X: 157.249, Y: 160.457, Z: 147.4421
Dimensions (Angstrom) X: 90.7434, Y: 105.0962, Z: 121.5736
6Protein geranylgeranyltransferase-I3DRACenter X: 28.7147 Y: 41.6649 Z: 20.5575
Dimensions (Angstrom) X: 83.9663, Y: 709289, Z: 64.3607
Table 2. Fatty acids profile from crude fat of elderflower analysed by GC–MS.
Table 2. Fatty acids profile from crude fat of elderflower analysed by GC–MS.
No. crtFatty Acid as Methyl EsterPercentage of Total Compounds (%)
1Palmitic acid C16:026.574 ± 0.68
2Linolenic acid C18:3 Δ9,12,15 (Z,Z,Z)12.794 ± 0.18
3Linoleic acid C18:2, Δ9,12(Z,Z)9.397 ± 0.62
4Oleic acid C18:1, Δ9 (Z)32.806 ± 0.82
5Stearic acid, C18:03.996 ± 0.28
6Arachidic acid, C20:01.025 ± 0.01
7Behenic acid, C22:01.944 ± 0.13
8Lignoceric acid, C24:04.554 ± 0.26
9Cerotic acid, C26:04.217 ± 0.50
10Montanic acid, C28:02.690 ± 0.37
Saturated Fatty Acids (SFA)45.002 ± 0.31
Monounsaturated Fatty Acids (MUFA)32.806 ± 0.82
Polyunsaturated Fatty Acids (PUFA)22.191 ± 0.39
Table 3. Volatile chemical constituents of SNEO analysed by GC–MS.
Table 3. Volatile chemical constituents of SNEO analysed by GC–MS.
No.
Crt
CompoundsPercentage of Total Compounds (%)RI c/
Rir
11,4-Hexadiene, 3,3,5-trimethyl- 1.82 ± 0.109960/964
2β-Linalool 1.56 ± 0.0521086/1089
31,5,7-Octatrien-3-ol, 3,7-dimethyl-1.55 ± 0.0531090/1089
4Nonanal 4.36 ± 0.0691098/1095
5cis-Rose oxide 3.87 ± 0.0701110/1112
6trans-Rose oxide 1.74 ± 0.0091129/1128
7Nerol oxide0.51 ± 0.0081150/1144
8Dihydroedulan II (cis)0.50 ± 0.0101280/1282
9Edulan I, dihydro-1.83 ± 0.0051320/1318
106,8-Nonadien-2-one, 6-methyl-5-(1-methyl ethylidene)-1.02 ± 0.0821380/1382
112-Pentadecanone, 6,10,14-trimethyl-1.96 ± 0.1911801/1804
12Heptadecane 7.96 ± 0.123
132,6-Octadiene, 2,6-dimethyl-0.57 ± 0.0481950/1948
14Octadecane 1.14 ± 0.275
151-Octadecanol 0.59 ± 0.0352085/2090
16Nonadecane 23.19 ± 0.409
17Eicosane 2.94 ± 0.051
189-Tricosene, (Z)-0.44 ± 0.0552270/2274
19Heneicosane 25.08 ± 0.498
20Docosane 2.06 ± 0.007
219-Hexacosene 1.07 ± 0.0652574/2570
22Tetracosane 9.35 ± 0.126
23Pentacosane 2.34 ± 0.112
24Squalene 1.95 ± 0.0922835/2833
25Tetratriacontane 0.50 ± 0.008
Total compounds100100
Terpene hydrocarbons1.95 ± 0.092
Oxygenated terpene11.59 ± 0.018
Alcohols2.14 ± 0.054
Aldehydes and ketones7.35 ± 0.076
Alkanes74.59 ± 0.116
Other (unsaturated hydrocarbons)2.38 ± 0.094
Table 4. The DPPH radical scavenging activity (% inhibition) of essential oil vs. ascorbic acid.
Table 4. The DPPH radical scavenging activity (% inhibition) of essential oil vs. ascorbic acid.
SamplesAcid Ascorbic
Concentration (mg/mL)SN
% Inhibition
Concentration (mg/mL)% Inhibition
2.0017.61 ± 0.060.00623.81 ± 0.03
4.0037.97 ± 0.060.00841.73 ± 0.06
6.6769.81 ± 0.070.01055.47 ± 0.05
10.0082.47 ± 0.060.01479.16 ± 0.08
20.0085.38 ± 0.030.01691.13 ± 0.06
Table 5. The IC50 value of the essential oil sample vs. ascorbic acid.
Table 5. The IC50 value of the essential oil sample vs. ascorbic acid.
SamplesSNAscorbic Acid
IC50 ± SEM2.520 ± 0.082 a2.525 ± 0.014 a
R20.92130.9919
Hill Slope18.00417.207
The results are presented as the mean of three determinations ± standard deviation (SD). (a) The mean differences between SN and ascorbic acid were compared using the ANOVA test; values with the same superscript are not statistically different (p > 0.05).
Table 6. Bacterial inhibition rates of SNEO against Gram-positive ATCC strains.
Table 6. Bacterial inhibition rates of SNEO against Gram-positive ATCC strains.
SNEO
mg/mL
S. pyogenesS. aureusL. monocytogenesB. cereusC. perfringens
0.1−36.61−61.5962.7957.25−39.25
0.125−19.73−48.5753.8556.39−7.28
0.25−6.87−1.786.5251.525.23
0.510.28−1.786.5743.5617.59
115.268.335.8238.8020.39
217.0614.992.2716.0722.70
422.0416.52−0.47−1.5732.76
830.2031.80−7.75−10.3938.62
1635.1839.45−12.20−10.8845.44
3242.2339.99−47.38−57.7959.21
IC50 mg/mL10.409.841.933.158.92
Table 7. Bacterial inhibition rates of SNEO against Gram-negative bacteria and Candida spp. ATCC strains.
Table 7. Bacterial inhibition rates of SNEO against Gram-negative bacteria and Candida spp. ATCC strains.
SNEO
mg/mL
P. aeruginosaS. lexneriE. coliS. typhimuriumH. influenzaeC. parapsilosisC. albicans
0.133.37−6.45−6.50−19.37−18.70−25.2773.78
0.12530.08−7.80−6.21−17.62−16.35−22.9572.37
0.2528.09−9.68−5.54−17.57−13.07−5.6159.96
0.525.90−11.24−4.51−11.68−10.84−4.7324.21
121.41−13.74−3.47−9.03−7.19−1.3913.73
215.04−15.71−2.59−3.42−4.742.7812.59
48.96−16.55−1.03−1.82−2.585.7011.40
82.59−18.21−0.679.37−1.1414.4610.08
160.50−19.46−0.1421.48−0.9734.264.24
32−8.27−22.163.2526.854.6043.30−24.90
IC50 mg/mL11.739.652.908.858.7212.073.08
Table 8. Docking scores of the most abundant compounds (ligands) and their binding interactions with microbial (1JIK, 6G9S, 8JZN, 3DRA) and oxidant proteins (2CAG, 2P31).
Table 8. Docking scores of the most abundant compounds (ligands) and their binding interactions with microbial (1JIK, 6G9S, 8JZN, 3DRA) and oxidant proteins (2CAG, 2P31).
S/NoLigandsPubChem IDBinding Energy (Kcal/mol)Interactions: Hydrophobic and Hydrophilic
1JIK6G9S8JZN3DRA2CAG2P311JIK6G9S8JZN3DRA2CAG2P31
1Nonanal31289−4.5−4.4−4.8−4.6−4.9−3.5Hydrophobic: Leu128, Ile131, Phe136, Leu173Hydrophobic: Arg68, Lys162, Val179
Hydrophilic: His203, Asp204
Hydrophobic: Ile1655, Phe1658, Val1745, Phe1811, Cys1814
Hydrophilic: His1654
Hydrophobic: Phe37, Met164, Trp300, Leu352
Hydrophilic: Tyr163, Thr375
Hydrophobic: Arg51, Ala112, Val125, Phe313, Tyr337, Ala340, His341
Hydrophilic: Ser93, Gly110
Hydrophobic: Val38, Pro113, Phe115Hydrophilic: Asn32
2cis-Rose oxide1712087−5.3−6.0−6.0−5.9−6.3−5.4Hydrophobic: Cys37, Ala39, Leu46, Pro53, Phe54, Ile103
Hydrophilic: His50
Hydrophobic: Ala65, Arg68, Tyr161, Lys162, Val179,
His203
Hydrophilic: Pro66
Hydrophobic: Ile713, Ile715, Phe821
Hydrophilic: Arg1182, Gln1376
Hydrophobic: Phe37, Arg160, Tyr163, Met164, Cys225, Trp300, Leu352Hydrophobic: Arg51, Arg52, Ala112, Val125, Phe313, Tyr337, Ala340Hydrophobic: Phe103, Arg106, Arg106
3trans-Rose oxide7093102−5.4−5.9−6.1−6.7−6.2−4.5Hydrophobic: Leu128, Ile131, Leu133, Phe136, Leu173Hydrophobic: Ala65, Arg68, Tyr161, Lys162, Val179Hydrophobic: His1654, Ile1655, Phe1658, Val1745Hydrophobic: Pro220, His249, Val252Hydrophobic: Ala112, Val125, Phe313, Tyr337, Ala340, His341
Hydrophilic: Arg51
Hydrophobic: Lys130, Ala133
4Edulan I, dihydro-521066−5.9−6.9−7.0−7.6−5.9−5.3NilHydrophobic: Tyr161, Arg163, His203NilNilNilNil
52-Pentadecanone, 6,10,14-trimethyl-10408−5.2−5.9−6.5−5.5−7.0−4.5Hydrophobic: Ile78, Ile131, Phe136, Tyr165Hydrophobic: Ala65, Arg68, Arg164, Val179 Hydrophobic: Tyr1451, Ala1454, Arg1684, Phe1687, Ala1742, Leu1746NilHydrophobic: Phe132, Phe140, His197, Leu278, Arg333, Tyr337, Ala340
Hydrophilic: Arg52, Omt53
Hydrophobic: Arg34, Val38, Pro113, Phe115
6Heptadecane12398−4.9−5.0−5.5−5.6−6.4−4.8Hydrophobic: Leu128, Ile131, Leu133, Phe136, Leu173Hydrophobic: Ala65, Arg68, Tyr161, Arg164, Val179, Ala201Hydrophobic: Tyr1451, Ala1454, Arg1455, Ile1680, Arg1684, Ala1742, Leu1746Hydrophobic: Phe37, Phe99, Arg160, Tyr163, Met164, His219, Phe222, Cys225, Trp300, Leu352Hydrophobic: Phe132, Phe140, His197, Leu278, Arg333, Tyr337, Ala340, His341Hydrophobic: Arg34, Lys98, Phe103, Arg106
7Nonadecane12401−5.0−3.7−6.1−4.7−6.6−4.0Hydrophobic: Met77, Leu128, Ile131, Phe136, Leu173Hydrophobic: Leu352, Pro355, Trp357, Trp358, Pro361Hydrophobic: His1654, Ile1655, Phe1658, Ala1742, Val1745, Leu1746, Val1749, Phe1811, Cys1814Hydrophobic: Tyr67, Trp106, Pro140, His145Hydrophobic: Arg51, His54, Ala112 Val125 Pro137, Phe140, Phe313, Met329, Arg333, Tyr337, Ala340, His341Hydrophobic: Lys98, Arg105, Arg106
8Eicosane8222−5.0−4.8−5.5−5.6−6.7−3.2Hydrophobic: Ile78, Leu128, Ile131, Leu133, Phe136, Leu173Hydrophobic: Ala65, Arg68, Tyr161, Lys162, Ala201Hydrophobic: His1654, Ile1655, Phe1658, Val1676, Ile1680, Ala1742, Val1745, Phe1811, Ile1815Hydrophobic: Phe37, Leu98, Phe99, Arg160, Tyr163, Met164, Leu167, His219, Phe222, Cys225, Trp300Hydrophobic: Arg51, Phe132, Phe140, His197, Leu278, Met329, Arg333, Tyr337, Ala340Hydrophobic: Arg106, Phe103
9Heneicosane12403−5.1−5.4−4.8−5.0−6.0−3.3Hydrophobic: Ile78, Leu128, Ile131, Leu133, Phe136, Leu137, Tyr165, Leu173Hydrophobic: Ala65, Arg68, Lys159, Tyr161, Lys162, Arg164, Val179Hydrophobic: Met458, Ile578, Tyr622, Val626, Phe629, Tyr633, Val1284, Leu1288 Hydrophobic: Ala33, Tyr36, Phe37, Leu98, Phe99, Pro140, Arg160, Val161, Tyr163, Met164, Cys225, Met348Hydrophobic: Arg52, Phe132, Phe140, Pro141, His197, Leu278, Arg333, Tyr337, Ala340Hydrophobic: Arg105, Arg106
10Docosane12405−4.9−4.9−5.6−5.2−6.4−4.1Hydrophobic: Leu128, Ile131, Phe136, Leu173Hydrophobic: Ala65, Arg68, Tyr161, Lys162, Arg164, Val179, His203Hydrophobic: Ile1507, Leu1510, Val1651, Ile1652, Ile1655, Phe1744, Val1807Hydrophobic: Tyr67, His145Hydrophobic: Arg51, Arg52, His54, Ala112, Val125, Pro137, Phe140, Phe313, Met329, Arg333, Tyr337, Ala340, His341Hydrophobic: Lys98, Arg105, Arg106
11Tetracosane12592−4.3−4.8−6.3−4.0−5.7−4.4Hydrophobic: Cys37, Ala39, His50, Pro53Hydrophobic: Ile64, Ala65, Arg68, Tyr161, Lys162Hydrophobic: Tyr1451, Ala1454, Arg1455, Ile1680, His1654, Ile1655, Phe1658, Ala1741, Ala1742, Val1745, Leu1746, Phe1811Hydrophobic: Leu20, Pro21, Ala24, Ile34, Pro347, Met348, His349Hydrophobic: Arg51, Arg52, His54, Ala112, Val125, Phe313, Tyr337, Ala340, Tyr343, Arg344Hydrophobic: His63, Arg65, Ala66, Leu70, Val165
12Pentacosane12406−4.9−3.9−5.4−5.0−5.9−3.4Hydrophobic: Ile78, Arg125, Leu128, Ile131, Phe136, Leu173Hydrophobic: Leu352, Phe353, Pro355, Trp358, Pro361Hydrophobic: Phe463, Trp464, Ala468, Val502, Ile681, Ala682, Phe685Hydrophobic: Tyr36, Phe37, Tyr67, Phe99, Arg160, Tyr163, Met164, Trp300, Met348Hydrophobic: Arg51, Arg52, Pro137, Phe140, Pro141, Met329, Arg333, Tyr337, Ala340Hydrophobic: Phe103, Arg105, Arg106
13Squalene638072−6.3−4.9−7.7−6.1−6.9−6.5Hydrophobic: Leu128, Phe136, Leu173Hydrophobic: Leu352, Pro355, Trp357, Trp358, Pro361Hydrophobic: Met458, Ile462, Met465, Tyr466, Tyr469, Ile578, Phe629, Tyr633, Tyr637, Leu1288Hydrophobic: Tyr67Hydrophobic: Phe132, Pro137, Leu138, Phe140, Pro141, Arg333Hydrophobic: Lys98, Phe103, Arg106
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Floares, D.; Obistioiu, D.; Hulea, A.; Suleiman, M.A.; Popescu, I.; Berbecea, A.; Samfira, I.; Radulov, I. Antimicrobial and Antioxidant Properties of Sambucus nigra L. (Elderflower) Oil: A Molecular Docking and Biochemical Study. Agronomy 2025, 15, 310. https://doi.org/10.3390/agronomy15020310

AMA Style

Floares D, Obistioiu D, Hulea A, Suleiman MA, Popescu I, Berbecea A, Samfira I, Radulov I. Antimicrobial and Antioxidant Properties of Sambucus nigra L. (Elderflower) Oil: A Molecular Docking and Biochemical Study. Agronomy. 2025; 15(2):310. https://doi.org/10.3390/agronomy15020310

Chicago/Turabian Style

Floares (Oarga), Doris, Diana Obistioiu, Anca Hulea, Mukhtar Adeiza Suleiman, Iuliana Popescu, Adina Berbecea, Ionel Samfira, and Isidora Radulov. 2025. "Antimicrobial and Antioxidant Properties of Sambucus nigra L. (Elderflower) Oil: A Molecular Docking and Biochemical Study" Agronomy 15, no. 2: 310. https://doi.org/10.3390/agronomy15020310

APA Style

Floares, D., Obistioiu, D., Hulea, A., Suleiman, M. A., Popescu, I., Berbecea, A., Samfira, I., & Radulov, I. (2025). Antimicrobial and Antioxidant Properties of Sambucus nigra L. (Elderflower) Oil: A Molecular Docking and Biochemical Study. Agronomy, 15(2), 310. https://doi.org/10.3390/agronomy15020310

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop